Provided By PR Newswire
Last update: Mar 11, 2025
NEW YORK, March 11, 2025 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by 2seventy bio, Inc. (NASDAQ: TSVT) and its board of directors concerning the proposed acquisition of the company by Bristol Myers Squibb (NYSE: BMY). Stockholders will receive $5.00 for each share of 2seventy bio stock that they hold. The transaction is valued at approximately $286 million and is expected to close in the second quarter of 2025.
Read more at prnewswire.com48.98
+0.96 (+2%)
Find more stocks in the Stock Screener